|
1 Indications And Usage Zoladex Is A Gonadotropin Releasing Hormone (Gnrh) Agonist Indicated For: Use In Combination With Flutamide For The Management Of Locally Confined Carcinoma Of The Prostate ( 1.1 ) Palliative Treatment Of Advanced Carcinoma Of The Prostate ( 1.2 ) The Management Of Endometriosis ( 1.3 ) Use As An Endometrial-Thinning Agent Prior To Endometrial Ablation For Dysfunctional Uterine Bleeding ( 1.4 ) Use In The Palliative Treatment Of Advanced Breast Cancer In Pre- And Perimenopausal Women ( 1.5 ) 1.1 Stage B2-C Prostatic Carcinoma Zoladex Is Indicated For Use In Combination With Flutamide For The Management Of Locally Confined Stage T2b-T4 (Stage B2-C) Carcinoma Of The Prostate. Treatment With Zoladex And Flutamide Should Start 8 Weeks Prior To Initiating Radiation Therapy And Continue During Radiation Therapy [See Dosage And Administration ( 2.1 ) And Clinical Studies ( 14.1 )]. 1.2 Prostatic Carcinoma Zoladex Is Indicated In The Palliative Treatment Of Advanced Carcinoma Of The Prostate [See Dosage And Administration ( 2.2 ) And Clinical Studies ( 14.2 )]. 1.3 Endometriosis Zoladex Is Indicated For The Management Of Endometriosis, Including Pain Relief And Reduction Of Endometriotic Lesions For The Duration Of Therapy. Experience With Zoladex For The Management Of Endometriosis Has Been Limited To Women 18 Years Of Age And Older Treated For 6 Months [See Dosage And Administration ( 2.3 ) And Clinical Studies ( 14.3 )]. 1.4 Endometrial Thinning Zoladex Is Indicated For Use As An Endometrial-Thinning Agent Prior To Endometrial Ablation For Dysfunctional Uterine Bleeding [See Dosage And Administration ( 2.4 ) And Clinical Studies ( 14.4 )]. 1.5 Advanced Breast Cancer Zoladex Is Indicated For Use In The Palliative Treatment Of Advanced Breast Cancer In Pre- And Perimenopausal Women. The Estrogen And Progesterone Receptor Values May Help To Predict Whether Zoladex Therapy Is Likely To Be Beneficial [See Dosage And Administration ( 2.5 ), Clinical Pharmacology ( 12.1 ), And Clinical Studies ( 14.5 )]. The Automatic Safety Feature Of The Syringe Aids In The Prevention Of Needlestick Injury.
|